Calumet Inc’s recently made public that its Director Sheets Daniel L unloaded Company’s shares for reported $0.42 million on May 13 ’25. In the deal valued at $13.88 per share,30,000 shares were sold. As a result of this transaction, Sheets Daniel L now holds 36,824 shares worth roughly $0.51 million.
Then, Sheets Daniel L sold 10,000 shares, generating $137,900 in total proceeds. Upon selling the shares at $13.79, the Director now owns 26,824 shares.
Before that, Mawer Stephen P sold 3,655 shares. Calumet Inc shares valued at $33,955 were divested by the Director at a price of $9.29 per share. As a result of the transaction, Mawer Stephen P now holds 283,652 shares, worth roughly $3.92 million.
BofA Securities initiated its Calumet Inc [CLMT] rating to a Buy in a research note published on May 13, 2025; the price target was $15. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in mid March from “a Sell” to “a Neutral”. TD Cowen also remained covering CLMT and has decreased its forecast on March 04, 2025 with a “Hold” recommendation from previously “Buy” rating. UBS revised its rating on February 04, 2025. It rated CLMT as “a Sell” which previously was an “a Neutral”.
Price Performance Review of CLMT
On Monday, Calumet Inc [NASDAQ:CLMT] saw its stock jump 0.66% to $13.82. Over the last five days, the stock has gained 5.34%. Calumet Inc shares have fallen nearly -37.24% since the year began. Nevertheless, the stocks have fallen -10.08% over the past one year.
How much short interest is there in Calumet Inc?
A steep rise in short interest was recorded in Calumet Inc stocks on 2025-04-30, growing by 0.57 million shares to a total of 9.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 8.79 million shares. There was a rise of 6.05%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 11, 2024 when TD Cowen resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $26.
